Is it still? The turn of events with how MPL could be used as an anti viral (potentially not just for Covid but other viruses as well) alongside other potential treatments in my opinion is much bigger upside than dog cancer treatment. As mentioned Remsdevir has generated Billions for Gilead. Remsdevir is an intravenous application. MPL is a tablet. If MPL is equally as effective as Remsdevir i know which one will be more popular and used at a much earlier timeframe once a virus has taken hold. The potential for MPL is huge. mTor inhibitors is a massively growing market as well. We have one with very little side effects in case studies done. Its application properties are extremely exciting.
Ann: Elanco Option Update, page-127
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $87.55M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $36.85K | 205.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 162181 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 412357 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |